AI assistant
IMMUTEP LIMITED — Director's Dealing 2022
Dec 21, 2022
65122_rns_2022-12-21_285656fc-97cc-4b7f-9b94-4739fbd6f410.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| Name of entity | IMMUTEP LIMITED (ASX: IMM) |
|---|---|
| ABN | 90 009 237 889 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Russell John Howard |
|---|---|
| Date of last notice | 1 December 2021 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest | Russell J Howard Pty Ltd < Russell J Howard |
| (including registered holder) | A/C> |
| Note: Provide details of the circumstances giving rise to the relevant | |
| interest. | |
| Date of change | 21 December 2022 |
| No. of securities held prior to change | 1. 1,000,000 Fully Paid Ordinary Shares |
| 2. 339,621 Director Performance Rights | |
| Class | Ordinary shares |
| Number acquired | 1. 113,207 ordinary shares |
| Number disposed | 2. 113,207 performance rights |
| Value/Consideration | |
| Note: If consideration is non-cash, provide details and estimatedvaluation | Nil for the issue of 113,207 shares. No |
| amount is payable upon exercise of the 1st | |
| tranche of Performance Rights which were | |
| approved by shareholders at the Annual | |
| General Meeting (AGM) held on 26 | |
| November 2021. |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 1. 1,113,207 Fully Paid Ordinary Shares2. 226,414 Director Performance Rights |
|---|---|
| Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back | 113,207 shares were issued upon vesting andexercising of 1st tranche of PerformanceRightsoutofthe339,621DirectorPerformance Rights which were issued inlieu of additional cash to compensate DrHoward for his additional responsibilities asChairman of the Company in accordancewith the Shareholders approval obtained atthe AGM held on 26 November 2021. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder(if issued securities) | |
| Date of change | |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | |
| Interest after change |
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed above No traded during a[+] closed period where prior written clearance was required?
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| If so, was prior written clearance provided to allow the trade toproceed during this period? | N/A |
|---|---|
| If prior written clearance was provided, on what date was thisprovided? | N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3